Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer
Abstract The characteristics of global prevalence and high recurrence of bladder cancer has led numerous efforts to develop new treatments. The spontaneous voiding and degradation of the chemodrug hamper the efficacy and effectiveness of intravesical chemotherapy following tumor resection. Herein, t...
Main Authors: | Cheng‐Che Chen, Yu‐Chen Fa, Yen‐Yu Kuo, Yi‐Chun Liu, Chih‐Yu Lin, Xin‐Hui Wang, Yu‐Huan Lu, Yu‐Han Chiang, Chia‐Min Yang, Li‐Chen Wu, Ja‐an Annie Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202204643 |
Similar Items
-
Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
by: Samantha Conroy, et al.
Published: (2023-05-01) -
Intravesical adriamycin in the management of bladder tumours Enugu experience
by: Aloy E Aghaji, et al.
Published: (1996-01-01) -
Intravesical prostatic protrusion correlates well with storage symptoms in elderly male patients with non-neurogenic overactive bladder
by: Shih-Yen Lu, et al.
Published: (2016-03-01) -
A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01) -
The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
by: Chong Yu, et al.
Published: (2023-01-01)